Mazabraud Yann's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Aug 14, 2026
- Accession no.
- 0001649904-26-000007
- Filed
- Aug 14, 2026, 7:01 PM ET
- Trade date
- Aug 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.62M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazabraud YannCIK 0001774702 | Officer (EVP, Head of International) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | MOption exerciseAcquired | +46,625 | $6.80 | +$317,050 | 112,655 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −2,300 | $111.80 | −$257,138.16 | 110,355 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −1,000 | $112.86 | −$112,856 | 109,355 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −3,605 | $114.70 | −$413,477.28 | 105,750 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −14,568 | $115.43 | −$1,681,540.54 | 91,182 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −18,208 | $116.49 | −$2,121,124.57 | 72,974 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −17,319 | $117.47 | −$2,034,438.68 | 55,655 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | MOption exerciseDisposed | −46,625 | $0.00 | $0 | 35,875 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.